Literature DB >> 12650670

Lack of inhibition of endothelial nitric oxide synthase in the isolated rat aorta by doxorubicin.

G J M den Hartog1, A W Boots, G R M M Haenen, W J F van der Vijgh, A Bast.   

Abstract

Besides inducing cardiotoxicity, doxorubicin also affects the vasculature. Recent observations in cultured endothelial cells indicated that the endothelial form of nitric oxide synthase might be inhibited by doxorubicin thereby seriously interfering with vascular function. We have investigated the effect of doxorubicin on the relaxation induced by the muscarinic agonist carbachol in the isolated rat aorta. It was found that doxorubicin at concentrations up to 50 microM does not alter the relaxant response to carbachol. Direct measurement of nitrite, the metabolite of NO*, by the Griess assay confirmed our observation that NO*)production is not inhibited by doxorubicin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650670     DOI: 10.1016/s0887-2333(03)00007-9

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  3 in total

1.  Effects of adriamycin and candesartan on the collagen and elastin of the aorta in rats.

Authors:  Jae-Sun Uhm; Woo-Baek Chung; Jung-Sook Yoon; Yong-Seog Oh; Ho-Joong Youn
Journal:  Clin Hypertens       Date:  2014-09-25

2.  Multi-targeted mechanisms underlying the endothelial protective effects of the diabetic-safe sweetener erythritol.

Authors:  Daniëlle M P H J Boesten; Alvin Berger; Peter de Cock; Hua Dong; Bruce D Hammock; Gertjan J M den Hartog; Aalt Bast
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

3.  Modulatory Effect of 2-(4-Hydroxyphenyl)amino-1,4-naphthoquinone on Endothelial Vasodilation in Rat Aorta.

Authors:  Javier Palacios; Fredi Cifuentes; Jaime A Valderrama; Julio Benites; David Ríos; Constanza González; Mario Chiong; Benjamín Cartes-Saavedra; Carlos Lafourcade; Ursula Wyneken; Pamela González; Gareth I Owen; Fabián Pardo; Luis Sobrevia; Pedro Buc Calderon
Journal:  Oxid Med Cell Longev       Date:  2016-09-08       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.